Collaboration Announced to Develop Hadassah Drug to Treat “Untreatable” NASH Liver Disease

Friday, Aug 5 2016

Hadasit, the Hadassah Medical Organization’s technology transfer company, has signed an agreement with BioLineRx Ltd. to develop a drug to treat non-alcoholic steatohepatitis (NASH), based on the pre-clinical work of Hadassah’s Prof. Rifaat Safadi, head of its Liver Unit. Currently, there are no Federal Drug Administration-approved treatments for NASH.

NASH is the progressive form of non-alcoholic fatty liver disease (NAFLD) and, in many cases, leads to cirrhosis of the liver and, ultimately, liver cancer. This “in-licensing agreement” represents a partnership between two companies with shared intentions, goals, and fields of interest. "Under the collaboration,” explains Dr. Kinneret Savitsky, Chief Executive Officer of BioLineRx,” Novartis will provide us with valuable professional advice and consultancy throughout the development process. This project fits our strategic focus on the immunology space, since it works through modulation of the immune system.”

The drug candidate, to be called BL-1210, offers a novel mechanism for controlling liver fibrosis, the scarring process that represents the liver's response to injury. When scar tissue builds up and takes over most of the liver, cirrhosis is the result. By modulating the immune system, the drug would reduce scarring and control the disease’s progression.

As Hadasit explains about the Hadassah Medical Center on its website, “The combination of practical experience, the ability to pinpoint medical needs, and cutting-edge research has yielded a huge potential for ideas, innovation, and developments in all aspects of medicine, including therapeutics, diagnostics, and medical devices. Founded in 1986, Hadasit has been investing in turning ideas into viable products and services for the benefit of humanity.”


From: Michelle on August 25, 2016
I was first diagnosed with NASH in 2003. Nobody I knew had ever heard of NASH. At the beginning even some of my doctors, often were unknowldgeable on NASH. I was their key to unlock the information vault. I am willing to be a test subject.
First Name
Enter this word:

Related Stories


Wednesday, Oct 19 2016

Caryn Andrews: Hadassah Nurse Practitioner on a Mission

Nurse Practitioner Caryn Scheinberg Andrews, who immigrated to Israel from Baltimore, Maryland in 2011 and is a lecturer in the Hadassah-Hebrew University Henrietta Szold School of Nursing, is on a personal mission: to fortify Israel's health delivery capacity by helping to create a cadre of advanced practice nurses.


Wednesday, Oct 5 2016

Russian Children Travel to Hadassah to be Treated For a Rare Disease

To date, Hadassah has treated over 14 Russian children, saving their sight and hearing and offering them the opportunity to grow up and live normal lives.


Wednesday, Sep 28 2016

Hadassah Medical Organization Goes on High Alert for Peres Funeral

Thousands of visitors, including high profile dignitaries, are expected to arrive in Jerusalem for the funeral of past Prime Minister and President Shimon Peres, who will be laid to rest on Friday, September 30.


Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.


Contact Us

40 Wall Street

New York, NY 10005


More ›

Membership Questions


(800) 664-5646

Donation Questions


(800) 928-0685

Missions Department


(800) 237-1517

Show More